Pediatrics
Showing 1,101-1,200 of 1,612 Results
-
Ruby Vishnu Patel
Clinical Assistant Professor, Pediatrics - Nephrology
BioI am a Clinical Assistant Professor in the Division of Pediatric Nephrology at Stanford. I have completed my pediatric nephrology fellowship from Stanford Children's Hospital and Residency as well as Chief Resident Year from The Kaiser Permanente Northern California Pediatrics Residency Program.
-
Debarun Patra
Postdoctoral Scholar, Cardiovascular Institute
BioDebarun Patra is a postdoctoral researcher at Stanford Medicine, with a background in inflammation research. His research focuses on metabolic disease modeling and identifying novel therapeutic targets. His current work integrates inflammatory and metabolic diseases (IBD, MASH, and diabetes), using patient-derived iPS cells and primary cells, and employs advanced multi-omics.
-
Jack Percelay
Clinical Professor, Pediatrics
BioJack Percelay has a 25+ year career in pediatric hospital medicine, beginning before the term hospitalist was invented when he started as an "in-house pediatrician in 1991 at several Bay Area hospitals after a brief career as a civilian primary care pediatrician at local and international US military bases. He has spent the majority of his career in community hospitals where his practice has run the gamut from the general pediatric ward and emergency room, to the PICU and intensive care nurseries, delivery room, and specialized neurologic and neurosurgical units. His work has taken him from San Francisco to New York City with brief stints in Hawaii. In 2015 he moved to Seattle Children's Hospital where he was an Associate Division Chief of Hospital Medicine, and in 2018 returned to the Bay Area joining the Stanford faculty.
He served as the founding chair of the AAP Section on Hospital Medicine, and has also served as the Chair of the AAP Committee on Hospital Care. He served for seven years as the pediatric board member for the Society of Hospital Medicine and has been recognized as a Master of Hospital Medicine by SHM. Additionally, he was an inaugural board member of the American Board of Pediatrics Pediatric Hospital Medicine Subspecialty Board. Areas of interest include pediatric hospital medicine systems of care, patient and family-centered care, BRUEs, billing and coding, and hospitalist roles in the PICU. -
Trung Hoang Minh Pham
Assistant Professor of Pediatrics (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsUncovering mechanisms of tissue immunity and immunophysiology during persistent infection
The immune system safeguards the health of complex organisms by rapidly eliminating invading pathogens, curbing infection-induced tissue disruptions, and maintaining tissue homeostasis. Many pathogens evade host antimicrobial mechanisms and persist in infected tissues at low levels for long periods of time even in the presence of innate and adaptive immune resistance. During persistent infection, the immune system simultaneously orchestrates antimicrobial responses to contain the pathogen, repairs damaged tissue, regulates nutrient resources, and maintains other tissue physiological functions to ensure host survival. Failure of any of these tasks leads to uncontrolled infection, devastating disease, and even death. The goals of our research are to understand:
1)What are the innate and adaptive immune cellular mechanisms that contain pathogens during persistent infection?
2)How are tissue physiological functions, such as tissue repair and nutrient regulation, maintained during persistent infection?
3)How do pathogens survive innate and adaptive antimicrobial mechanisms in infected tissues?
4)How does persistent infection impact host immunity to secondary infections of a similar or different pathogen?
Through investigating these fundamental questions, we may be able to decode the underlying cellular and molecular mechanisms that can be harnessed to eradicate infections, promote tissue resilience, and restore health after an infectious insult. We integrate immunology, tissue biology, microbiology, and genetics to uncover the mechanisms of tissue immunity and immunophysiology during persistent infection from the molecular to organismal level.
Current areas of research:
•Development, maintenance, and plasticity of macrophage functional diversity in infected tissue
•Tissue repair and nutrient regulation during persistent infection
•Cellular dynamics and bacterial persistence in lymphoid organs -
Lisa Pineda
Senior Simulations Specialist, Pediatrics - Neonatology
BioLisa received a Bachelor of Science in Kinesiology with an emphasis in Athletic Training from San Jose State University, a Master of Science in Perinatal Clinical Nurse Specialist/Neonatal Emphasis from the University of California San Francisco, and a Post-Graduate Family Nurse Practitioner Certificate from San Francisco State University.
Lisa started her nursing career at Lucile Packard Children’s Hospital in the Labor and Delivery Unit. It became clear early in her career that research-driven high-quality patient-centered care was integral to her learning and passion for nursing. As a staff nurse, she participated in multiple obstetric simulations at CAPE, and she was immediately drawn to the systematic approach, clear communication, and debriefing process within the simulation methodology. For more than two decades, Lisa’s work has included bedside nursing, advanced practice nursing for women and children, and public health nursing with a particular passion for research dedicated to improving patient outcomes. -
Benjamin Pinsky
Professor of Pathology, of Medicine (Infectious Diseases) and, by courtesy, of Pediatrics (Infectious Diseases)
Current Research and Scholarly InterestsDevelopment and application of molecular assays for the diagnosis and management of infectious diseases.
-
Terry Platchek
Clinical Professor, Pediatrics
Clinical Professor, Emergency Medicine
Clinical Professor, Emergency Medicine
Clinical Professor (By courtesy), Medicine - Primary Care and Population HealthCurrent Research and Scholarly InterestsDr. Platchek's research interest focuses on improving value in healthcare delivery using healthcare model design thinking and a "Lean" business strategy. Dr. Platchek is also interested in effective methods for engaging clinicians in systems-based clinical improvement efforts.
-
Celeste Poe, Ph.D., PMH-C
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Clinical Assistant Professor (By courtesy), PediatricsBioDr. Celeste Poe is a licensed clinical psychologist with a certification in perinatal mental health. She completed her residency and fellowship training at the Yale Child Study Center. She received her Ph.D. from Palo Alto University, her master’s degree from Pepperdine University and she is a proud HBCU alumni of Xavier University of Louisiana where she received her bachelor’s degree.
Dr. Poe is a Clinical Assistant Professor and Attending NICU and Perinatal Psychologist at Stanford University School of Medicine. She is the program director of the maternal & infant critical care mental health services at Lucile Packard Children's Hospital where she provides psychological consultation and psychotherapy to parents requiring hospitalization due to high risk pregnancies and parents of infants hospitalized in the NICU. Dr. Poe’s clinical specialties include perinatal and infant mental health as well as maternal-infant critical care with a focus on child and caregiver trauma, grief, and bereavement. Her research focuses on Black perinatal mental health and mental health equity, infant and parent mental health in medical settings, and intergenerational trauma. Dr. Poe was a Zero to Three Fellow and currently serves as Co-Chair of the National Network of NICU Psychologists. In 2026 she was appointed to the American Psychological Association's committee on Children Youth and families.
Dr. Poe also holds a community faculty appointment as an Assistant Clinical Professor at the Yale Child Study Center where she works on the Grief-Sensitive Healthcare Project which aims to enhance healthcare providers’ capacities to meet the needs of grieving families. -
Matthew Porteus
Sutardja Chuk Professor of Definitive and Curative Medicine
BioDr. Porteus was raised in California and was a local graduate of Gunn High School before completing A.B. degree in “History and Science” at Harvard University where he graduated Magna Cum Laude and wrote an thesis entitled “Safe or Dangerous Chimeras: The recombinant DNA controversy as a conflict between differing socially constructed interpretations of recombinant DNA technology.” He then returned to the area and completed his combined MD, PhD at Stanford Medical School with his PhD focused on understanding the molecular basis of mammalian forebrain development with his PhD thesis entitled “Isolation and Characterization of TES-1/DLX-2: A Novel Homeobox Gene Expressed During Mammalian Forebrain Development.” After completion of his dual degree program, he was an intern and resident in Pediatrics at Boston Children’s Hospital and then completed his Pediatric Hematology/Oncology fellowship in the combined Boston Chidlren’s Hospital/Dana Farber Cancer Institute program. For his fellowship and post-doctoral research he worked with Dr. David Baltimore at MIT and CalTech where he began his studies in developing homologous recombination as a strategy to correct disease causing mutations in stem cells as definitive and curative therapy for children with genetic diseases of the blood, particularly sickle cell disease. Following his training with Dr. Baltimore, he took an independent faculty position at UT Southwestern in the Departments of Pediatrics and Biochemistry before again returning to Stanford in 2010 as an Associate Professor. During this time his work has been the first to demonstrate that gene correction could be achieved in human cells at frequencies that were high enough to potentially cure patients and is considered one of the pioneers and founders of the field of genome editing—a field that now encompasses thousands of labs and several new companies throughout the world. His research program continues to focus on developing genome editing by homologous recombination as curative therapy for children with genetic diseases but also has interests in the clonal dynamics of heterogeneous populations and the use of genome editing to better understand diseases that affect children including infant leukemias and genetic diseases that affect the muscle. Clinically, Dr. Porteus attends at the Lucille Packard Children’s Hospital where he takes care of pediatric patients undergoing hematopoietic stem cell transplantation.
-
Allison Pribnow
Clinical Assistant Professor, Pediatrics - Hematology & Oncology
Current Research and Scholarly InterestsSolid Tumors, Bone Sarcomas, Global Oncology, Health Disparities
-
James Priest
Adjunct Clinical Assistant Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsThe Priest lab seeks a better understanding of the genetics and pathogenesis of congenital heart disease using translational genomics, big-data, and vertebrate models of cardiac development.
-
Prince Allawadhi
Postdoctoral Scholar, Gastroenterology, Hepatology, and Nutrition
BioMy research focuses on immune-stromal crosstalk in pancreatic diseases, with an emphasis on how myofibroblasts and macrophages drive inflammation, fibrosis, and multi-organ dysfunction. By integrating mice models, patient-derived organoids, zebrafish models, and multi-omics, I aim to unravel the cellular and molecular mechanisms underlying pancreatic injury and repair. I am developing cutting-edge zebrafish models of exocrine pancreas disorders to uncover novel immuno-fibrotic pathways and accelerate the identification of translational targets for early diagnosis and therapeutic intervention.
-
Lance Prince
Philip Sunshine, MD, Professor of Neonatology
BioLawrence (Lance) S. Prince, MD, PhD, is the Philip Sunshine Endowed Professor of Pediatrics at Stanford School of Medicine. Dr. Prince was previously a Professor of Pediatrics and Chief of the Division of Neonatology at the University of California, San Diego and Rady Children’s Hospital, San Diego.
Dr. Prince has a long and distinguished career mentoring clinical and scientific trainees and students, many of whom have gone on to establish their own successful careers as academic physician investigators. As a physician scientist, Dr. Prince leads a basic science laboratory focusing on the mechanisms regulating developmental immunology and lung injury and repair. Dr. Prince received a Bachelor of Science in Chemistry from University of Miami, an MD/PhD with a focus in Cell Biology from University of Alabama at Birmingham, and postdoctoral fellowship, Pediatrics residency, and Neonatal-Perinatal Medicine Fellowship training at the University of Iowa. Before arriving in California, Dr. Prince was an Associate Professor of Pediatrics at Vanderbilt University.
Dr. Prince’s research interests include the molecular and cellular mechanisms controlling lung development and the maturation of the fetal and neonatal immune systems. He has a particular clinical interest in managing and treating neonatal lung diseases, especially bronchopulmonary dysplasia (BPD) in babies born extremely preterm. Dr. Prince’s research team focuses primarily on the development of innate immunity during fetal life as it impacts health and disease in preterm infants. The laboratory is investigating how microbes including Group B streptococcus exploit the unique features of neonatal macrophages to avoid immune detection and cause disease, as well as leading a number of clinical and translational investigations. -
Charles G. Prober, MD
Professor of Pediatrics (Infectious Diseases) and, by courtesy, of Microbiology and Immunology
Current Research and Scholarly InterestsMy research interest is in the epidemiology, pathophysiology, prevention, and treatment of infections in children. Much of this research has focused on viral infections, especially those caused by herpes simplex virus (HSV). I have conducted a number of studies concerned with the epidemiology of HSV-2 infections in pregnant women, their partners, and neonates.
-
Jochen Profit
Wendy J. Tomlin-Hess Endowed Professor
Current Research and Scholarly InterestsFunded by NIH R01 grants:
1) Development and application of composite measure of NICU quality - Baby-MONITOR
2) High reliability, safety culture and caregiver resilience as modifiers of care quality
3) Modifiable racial/ethnic disparities in quality of care delivery
4) Effectiveness of regionalized care delivery systems for preterm newborns -
Rajesh Punn, M.D.
Clinical Professor, Pediatrics - Cardiology
BioDr. Rajesh Punn is a pediatric cardiologist and clinical professor at Stanford University with expertise in advanced echocardiography, congenital heart disease imaging, and fetal cardiology. He serves as Director of Ambulatory Cardiology at the Stanford Pediatric Heart Center, where his work focuses on optimizing outpatient care delivery and integrating imaging into clinical decision-making.
His academic interests center on ventricular function, fetal and pediatric echocardiography, and translational imaging applications in congenital heart disease. He is actively involved in multicenter research collaborations and has authored over 80 peer-reviewed publications. Dr. Punn also serves as Associate Editor for the Journal of the American Society of Echocardiography.
In addition to his clinical and research work, he is deeply engaged in mentorship of fellows, residents, and medical students, with a focus on developing the next generation of clinicians and physician-scientists in pediatric cardiology. -
Yanli Qiao
Life Science Rsch Prof 3, Pediatrics - Gastroenterology
BioDr. Yanli Qiao has worked at Stanford for many years, and joined the Rosen Laboratory in 2022. She works with transgenic mice to understand the mechanistic etiology of ulcerative colitis (UC). Specifically, she studies how Th2 responses shape epithelial differentiation and repair in acute and chronic colitis. She also investigates how ILC2s contribute to epithelial homeostasis using both animal and human organoid models of disease in UC. In her free time, Yanli enjoys gardening and cooking Chinese food for her family.
-
Naveed Rabbani
Adjunct Clinical Assistant Professor, Clinical Informatics
BioDr. Naveed Rabbani is a physician executive in health information technology and medical AI researcher. He currently serves as Associate Chief Medical Information Officer at Sutter Health, a large nonprofit health system in California. In this role, he leads a portfolio of enterprise-wide clinical IT programs including ambient documentation and generative AI implementation. He also holds a research appointment at Harvard Medical School in the Department of Biomedical Informatics. A nationally recognized expert in health information technology, Dr. Rabbani is an Executive Committee Member for the American Academy of Pediatrics' Council on Clinical Information Technology and the Epic EHR Pediatric Primary Care Steering Board. As adjunct faculty at Stanford, he teaches in the Clinical Informatics Fellowship in the School of Medicine and conducts research in the Division of Clinical Informatics. Dr. Rabbani holds a BS in Electrical Engineering from Stanford University and an MD from Harvard Medical School.
-
Jennifer Anne Rabbitts
Professor of Anesthesiology, Perioperative & Pain Medicine (Pediatric) and, by courtesy, of Pediatrics
BioJennifer Rabbitts, MD is Professor and Chief of Pediatric Pain Management at Stanford University School of Medicine. Dr. Rabbitts directs an NIH-funded research laboratory focused on improving long-term pain and health outcomes in children and adolescents undergoing surgery. Her research is devoted to understanding and preventing chronic postsurgical pain, a disabling condition affecting 20% youth undergoing major surgery. Her current research studies investigate the role of biopsychosocial mechanisms including child psychosocial factors, parental/family factors, and psychophysical processes underlying acute to chronic pain transition. Current clinical trials focus on testing feasibility and efficacy of psychosocial and complementary and integrative interventions to improve acute postsurgical pain and prevent transition to chronic pain.
Dr Rabbitts is passionate about mentoring, and is a PI for the NIH HEAL PAIN Training grant in Maternal and Child Pain and Health at Stanford. She serves as section editor for Psychology, Psychiatry and Brain Neuroscience Section for Pain Medicine, and serves on the editorial boards for Pediatric Anesthesia and Journal of Pain.
Read more about the Rabbitts Lab and opportunities here: https://rabbittslab.stanford.edu/ -
Marlene Rabinovitch
Dwight and Vera Dunlevie Professor of Pediatric Cardiology
Current Research and Scholarly InterestsOur research program seeks to identify the cellular and molecular programs regulating vascular and lung development, through the use of cultured cells and tissues and mouse and rat models. We then determine how these programs are perturbed by genetic abnormalities or injurious processes associated with disease, focusing on pulmonary arterial hypertension (PAH), a fatal complication in children with heart defects, and a condition of unknown etiology primarily in young women.
-
Nilima Ragavan
Clinical Professor, Pediatrics - Neonatology
BioDr Nilima Ragavan is a Neonatologist and Clinical Professor at the Stanford University School of Medicine. She is an experienced clinician who has expertise in the care of critically ill newborns.She is the Neonatal Outreach Medical director for Stanford Children's health, Co director of the Mid Coastal California Perinatal Outreach Program, and the Medical director of the Special care Nursery at Stanford Children's Health.She serves as a mentor to junior faculty. Dr Ragavan is passionate about education, and social justice. She has worked in and promoted social organizations in the fields of education, health care, livelihood and women's empowerment in India.She founded a group called Teach to Heal to promote cross cultural education and has led several multidisciplinary medical teams to India, as well as organized and conducted international neonatal and perinatal conferences.
-
Alireza Raissadati, MD, PhD
Instructor, Pediatrics - Cardiology
Fellow in Pediatrics - CardiologyBioDr. Raissadati is a Pediatric Cardiology Attending Physician at Lucile Packard Children's Hospital specializing in Advanced Cardiac Therapies. With dual PhDs in medicine and biotechnology, his research focuses on developing non-invasive molecular tools to understand and treat heart failure and transplant rejection, with the goal of identifying new diagnostic and therapeutic targets for acute rejection and vasculopathy of the heart transplant.
-
Nitya Rajeshuni
Clinical Assistant Professor, Pediatrics - Critical Care
BioDr. Rajeshuni is a Clinical Instructor in the Department of Pediatrics at Stanford University. She is faculty with the Stanford Center for Asian Health Research and Education (CARE), the Center for Innovation in Global Health (CIGH), and the Maternal Child Health Research Institute (MCHRI). Dr. Rajeshuni earned her BS, MS in Epidemiology and Clinical Research, and MD from Stanford University. She completed residency training at the University of Pennsylvania and a Biodesign innovation fellowship at Harvard University.
Her research centers on advancing health equity among racial and ethnic minorities, with a particular focus on Asian populations. She investigates health disparities, access to care, and the implementation and evaluation of public and digital health solutions in the U.S. and low- and middle-income countries. Current projects include studying the impacts of maternal education and intimate partner violence on child outcomes. Her broader interests encompass promoting resilience and well-being in vulnerable communities worldwide and leveraging digital health to reduce health disparities. She is a recipient of a career development award through the CHIME Health Equity Scholars program funded by PCORI and will be studying the effects of social supports on resilience in pregnant people of minority descent. Her global collaborations include work with NGO Arogya World on diabetes prevention in India as a collaborator and member of the Board. She is also the Director of South Asia Outreach at Stanford CARE. She also serves as a Product Advisor to healthcare startup Yuimedi.
Dr. Rajeshuni is deeply committed to teaching and mentorship. At Stanford, she serves as Associate Program Director for CARE Scholars and the Team Science Fellowship, year-long data science programs that provide emerging researchers with structured mentorship, advanced analytical skills, and interdisciplinary collaboration to drive health equity research. She is Faculty Co-Director of FAMMED 210: The Healer’s Art, an international program offering a reflective, experiential course designed to nurture compassion, resilience, and the humanistic values essential to medicine. She mentors graduate, undergraduate, and high school students at Stanford and beyond, and serves as Faculty Advisor in the Department of Human Biology.
Outside academia, Dr. Rajeshuni is an accomplished vocalist, performing professionally with world music ensembles Wobbly World and San Francisco’s Peña Pachamama Carnaval Arts Program. -
Sneha Ramakrishna
Assistant Professor of Pediatrics (Hematology/Oncology)
BioSneha Ramakrishna obtained her B. A. from the University of Chicago and her M.D. from the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. In medical school, through the Howard Hughes Medical Research Scholar Award, she joined Dr. Crystal Mackall’s laboratory, where she designed and developed various GD2 CAR-Ts and tested them in preclinical models. During her residency training in Pediatrics at the Children’s Hospital of Philadelphia, she cared for some of the first patients treated with CD19 CAR T cells, learning the power of this therapy first-hand. During her fellowship in Pediatric Hematology/Oncology at the Johns Hopkins/National Cancer Institute combined program, she worked with Dr. Terry Fry. She evaluated the mechanism of CD22 CAR T cell relapse in patients by developing an antigen escape model and establishing a deeper understanding of the effects of antigen density on CAR-T phenotype, expansion, and persistence (Fry…Ramakrishna…Mackall Nat Med, 2018; Ramakrishna, et al., Clinical Cancer Research, 2019). Since arriving at Stanford, Dr. Ramakrishna leads an interdisciplinary team that designs, develops, and successfully implements a robust correlative science platform for our novel CAR-T therapies. Analyzing patient samples from our first-in-human GD2 CAR-T trial (NCT04196413) treating a universally fatal cancer, diffuse midline glioma (DMG), we identified that intracerebroventricular CAR-T administration correlates with enhanced pro-inflammatory cytokines and reduced immunosuppressive cell populations in cerebrospinal fluid as compared to intravenous CAR-T administration (Majzner*, Ramakrishna*, et al., Nature 2022 *co-first authors). Her research program evaluates unique sets of patient samples using novel single-cell immune profiling to identify the drivers of CAR-T success or failure. Building on these findings, her team assesses approaches to enhance CAR-T efficacy and translate these findings to the clinic.
Clinically, Dr. Ramakrishna cares for children with solid tumors and treats hematologic, solid, and brain tumor pediatric patients with CAR T cell therapies in the Cancer Cellular Therapies program. -
Mahalakshmi Ramamurthy
Affiliate, Peds/Developmental-Behavioral Pediatrics
BioI am a postdoctoral scholar working with Dr. Jason Yeatman. With a background in vision science, psychophysics and developmental cognitive neuroscience my long-term goal is to study the intersection of basic visual mechanisms and various neurodevelopmental disorders and to extend this understanding in creating effective early screening tools, and in advancing evidence-based therapeutic and remediation programs. Inherent to this interest is the need for developmental data in large and demographically diverse populations. I strongly believe that such inclusive research not only contributes to scientific advancements but can go beyond to bridge health and education disparities.
https://sites.google.com/view/maha-ramamurthy/bio -
Julia Raney
Assistant Professor of Pediatrics (Adolescent Medicine)
Current Research and Scholarly InterestsAdolescents are dying from drug overdoses at unprecedented rates, largely secondary to fentanyl contamination in the drug supply. A Youth Overdose Prevention Toolkit for school-based health centers is needed to combat this trend. The toolkit should include key stakeholder-informed harm reduction approaches that focus on reducing injury or death from fentanyl and other opioids without exclusively recommending abstinence; this approach is evidence-based and critical to saving lives.
-
Anoop Rao
Assistant Professor of Pediatrics (Neonatology)
Current Research and Scholarly InterestsWearable senors, unobtrusive vital sign monitoring, natural language processing/text mining
-
Lindsey Rasmussen
Clinical Professor, Pediatrics - Critical Care
Clinical Professor (By courtesy), Adult NeurologyCurrent Research and Scholarly InterestsMy research interests reside in the field of Neurocritical Care Medicine and stem from my experience developing and directing Stanford's comprehensive Pediatric Neurocritical Care program. I am interested in neuro-prognostication and neuro-monitoring in the pediatric intensive care setting. These interests are integrated clinically to focus on optimal care for pediatric patients with neurologic injury, through specialized nursing and physician care, protocols, and physiologic considerations.
-
Caroline E. Rassbach
Clinical Professor, Pediatrics
Clinical Professor, Emergency MedicineCurrent Research and Scholarly InterestsMedical education including learner assessment, program development and mentoring and coaching in medicine.
-
Sushma Reddy
Associate Professor of Pediatrics (Cardiology)
Current Research and Scholarly InterestsMy laboratory's expertise in cardiovascular phenotyping has led to the development of mouse models of congenital heart disease that recapitulate abnormal loading conditions on the heart. We have used these models to advance our understanding of the mechanisms of right heart failure in children and adults with congenital heart disease with the long term goal of identifying noninvasive diagnostic tools to better assess right ventricular health and to develop right ventricle specific therapeutics.
-
Shobha Regmi
Research Scientist, Pediatrics - Gastroenterology
BioDr. Regmi earned her PhD in Pharmacy from Yeungnam University, South Korea. Before joining us, she was a postdoctoral fellow in the Department of Radiology under the mentorship of Dr. Avnesh S. Thakor. With over a decade of experience researching novel therapies for inflammatory diseases and expertise in cell therapy, Dr. Regmi brings valuable skills in in vivo and in vitro experimental biology, immunology, complex multicolor flow cytometry, and scientific writing. Her expertise will be instrumental in advancing the Rosen Lab’s research on the molecular mechanisms underlying pediatric IBD and treatment response.
Dr. Regmi’s work will focus on investigating the role of stromal-immune crosstalk that drives ulcerative colitis. -
David Rehkopf
Director, Stanford Center on Longevity, Professor of Epidemiology and Population Health, of Sociology, of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics, and of Health Policy
BioI am a social epidemiologist and Professor in the Department of Epidemiology and Population Health, the Department of Sociology, and the Division of Primary Care and Population Health in the Department of Medicine. I joined the Stanford University faculty in 2011.
My research examines the health implications of the myriad decisions made every day by corporations and governments—decisions that profoundly shape the social and economic worlds in which we live and work. Although these changes are often invisible in daily life, seemingly minor actions and decisions can serve as structural nudges that produce better or worse health at the population level. My work documents the health consequences of corporate and governmental decisions, providing evidence that can help the public and policymakers develop new strategies to promote health and well-being. Across this work, I focus particularly on the implications of these exposures for health inequalities.
Because policy and programmatic changes can take decades to influence health, my research also includes more basic work to identify biological signals that may serve as early warning signs of systemic disease, particularly accelerated aging. I examine how social and economic policy changes affect a range of early markers of disease and aging, with a recent focus on DNA methylation. I am supported by several grants from the National Institute on Aging and the National Institute on Minority Health and Health Disparities to develop more sensitive approaches for understanding the health effects of social and economic policy changes. -
Jenna Reisler
Fellow in Peds/Clinical Informatics
BioJenna Reisler, MD is an Internal Medicine-trained Clinical Informatics Fellow passionate about designing clinical decision support tools that reduce clinician burden and improve patient outcomes. Her work spans CDS for falls prevention, human-centered EHR workflow design, and quality improvement in ambulatory care and inpatient settings. Recent projects include a co-investigator role on an EPIC-based falls prevention CDS tool published in Applied Clinical Informatics, and co-PI of an ACGME Back to Bedside–funded home visit program integrating social determinants of health into residency training.
-
David A. Relman
Thomas C. and Joan M. Merigan Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsMy investigative program focuses on human-microbe interactions and human microbial ecology, and primarily concerns the ecology of human indigenous microbial communities; a secondary interest concerns the classification of humans with systemic infectious diseases, based on features of genome-wide gene transcript abundance patterns and pther aspects of the host response.
-
Chloe Reuter
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Clinical Associate Professor, Pediatrics - Medical GeneticsBioChloe Reuter is a Genetic Counselor and Clinical Associate Professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine. She is Principal Investigator of an NIH-funded research program focused on developing frameworks for the clinical translation of multi-omic technologies in rare diseases.
Ms. Reuter provides genetic counseling care at the Stanford Center for Inherited Cardiovascular Diseases, specializing in inherited cardiovascular conditions including cardiomyopathies, arrhythmia syndromes, and sudden cardiac death. She has expertise in interpreting complex genomic results from multi-gene panels, exome sequencing, and whole genome sequencing for patients with rare and undiagnosed diseases.
Ms. Reuter's research centers on translating cutting-edge genomic technologies into clinical practice. She develops frameworks for integrating multi-omic data (genomic, transcriptomic, and other omics) into diagnostic workflows and contributes to evidence-based guidelines for variant interpretation and clinical curation. Her work addresses the ethical and practical challenges of implementing these technologies, with particular focus on patient engagement, equitable access to precision medicine, and protocols for returning complex research results. She also conducts genetic counseling practice research, examining patient experiences, psychosocial assessment tools, and healthcare delivery models including telehealth services.
She has contributed to multiple national genomics initiatives including the Undiagnosed Diseases Network and the GREGoR Consortium, applying comprehensive genomic approaches to solve medical mysteries and improve diagnostic outcomes for patients with rare diseases. -
William Rhine
Emeritus Faculty-Med Ctr Line, Pediatrics - Neonatology
Current Research and Scholarly InterestsNeonatology, extracorporeal membrane oxygenation, nitric oxide therapy, mechanisms of bilirubin toxicity and brain injury, non-invasive biotechnologies to study cellular and organ metabolism.
-
Brian Richter
Associate Director of Division Operations, Pediatrics - Hematology/Oncology
Current Role at StanfordAssociate Director of Division Operations, Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation, & Regenerative Medicine
-
Julia Rickenbacher Zhou
Office of Child Health Equity Program Manager, Pediatrics - General Pediatrics
Current Role at StanfordOffice of Child Health Equity Program Manager
